Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹1,913 Cr₹1,991 Cr₹1,913 Cr₹1,282 Cr₹1,433 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,913 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹1,913 Cr
Mar2025₹1,991 Cr
Mar2024₹1,913 Cr
Mar2023₹1,282 Cr
Mar2022₹1,433 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹1,913 Cr
-3.92
Mar2025 ₹1,991 Cr
4.08
Mar2024 ₹1,913 Cr
49.23
Mar2023 ₹1,282 Cr
-10.58
Mar2022 ₹1,433 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,399.2 Cr 10.3% 4.5% -5.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹442,437.0 Cr -0.5% -3% 16% Stock Analytics
DIVIS LABORATORIES ₹248,054.0 Cr 1.6% 9.3% 54.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,842.0 Cr 3.5% 2.3% 40.6% Stock Analytics
CIPLA ₹111,565.0 Cr 1.6% -3.2% -11.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,163.0 Cr 5.8% 3.2% -8.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

10.3%

4.5%

-5.4%

SENSEX

0.7%

-3.9%

-8.9%


You may also like the below Video Courses